Explorer les evidences

Palier Gold : evidences validées mécaniquement, avec leur source primaire.

8 823 evidences · page 91 / 353

62,6 %62.6% of respondents are willing to use HIVST sometimes in the future.

NigeriaVIH/sidapublié 2022The Pan African medical journalPubMeddocument de 6 observations

16 patientsAmlodipine monotherapy reduced diastolic blood pressure to below 90 mmHg in all but four of the 20 patients after a 10-week trial.

Nigeriahypertension artériellepublié 1996PubMedOpenAlexdocument de 3 observations

1,09 AORIncreasing age was significantly associated with chronic kidney disease (CKD) among antiretroviral therapy (ART)-naïve people living with HIV (PLWH) in Lagos, Nigeria, with adjusted odds ratios of 1.09 (95% CI: 1.06–1.12) using the Chronic kidney disease Epidemiology Collaboration (CKD-EPI) equation.

Nigeriamaladie rénale chroniquepublié 2024BMC nephrologyPubMeddocument de 15 observations

2,01 μg/mLLes extraits méthanoliques de Citrullus colocynthis présentent un IC50 de 2,01 μg/mL sur la souche 3D7 de Plasmodium falciparum et de 6,9 μg/mL sur la souche K1.

Nigeriapaludismeobservé 2017HAL · Unilimdocument de 173 observations

2,59 odds_ratioMultiple stepwise logistic regression showed that poor HbA1c control is a common predictor of PAD with odds ratio 2.59, 95% confidence interval 1.50–5.71, and p < 0.001.

NigeriaAOMIpublié 2023Foot (Edinburgh, Scotland)PubMeddocument de 23 observations

38,6 %Malaria prevalence was 38.6% by microscopic test in rural communities of Ebonyi State, Nigeria.

Nigeriapaludismepublié 2022The Korean journal of parasitologyPubMeddocument de 10 observations

73,5 %Among hypertensive patients in Ibadan, Nigeria, systolic-diastolic hypertension prevalence was 73.5% among males and 77.6% among females.

Nigeriasystolic-diastolic hypertensionpublié 2014International journal of hypertensioneurope_pmcdocument de 9 observations

38 casesThere were 38 (7.7%) severe cases and 459 (92.3%) non-severe cases among the 497 SARS-CoV-2 cases.

NigeriaCOVID-19observé April to July 2020publié 2022The Pan African medical journalPubMeddocument de 13 observations

4,15 cmLeft kidney breadth was significantly greater in sickle cell anemia patients (4.15 ± 0.92 cm vs. 3.79 ± 0.48 cm).

Nigeriadrépanocytosepublié 2023Nigerian journal of clinical practicePubMeddocument de 9 observations

11,67 %Malaria RDT result was positive in 7/60 (11.67%) of the first-line cART experienced HIV-infected participants.

Nigeriapaludisme · VIH/sidaobservé 2018–2019publié 2024BMC infectious diseasesPubMeddocument de 15 observations

68 patientsSixty-eight had leg ulcers.

Nigeriadrépanocytosepublié 2021Hematology (Amsterdam, Netherlands)PubMeddocument de 16 observations

120 patientsDuring follow-up, 120 patients developed patent gametocytaemia.

Nigeriapaludismepublié 2004Parasitologyeurope_pmcdocument de 10 observations

4 %Glucose-6-phosphate dehydrogenase deficiency was present in 4% of homozygous females (22/598) among enrolled patients.

Nigeriaglucose-6-phosphate dehydrogenase deficiencypublié 2009PLoS ONEOpenAlexdocument de 9 observationsDOI 10.1371/journal.pone.0006682

65,1 %Among non-diabetic respondents in a cross-sectional survey, 65.1% of overweight participants were at high risk of developing type 2 diabetes.

Nigeriadiabète de type 2publié 2021African health sciencesPubMeddocument de 10 observations

4,9 odds_ratioA child is five times more likely to die from severe malaria in the COVID-19 era than in the pre-COVID era (odds ratio = 4.9, 95% CI 2.008–11.982).

Nigeriapaludismeobservé 2019, 2020publié 2022Impact of COVID-19 on outcomes of childhood severe malaria: A comparative of study pre-COVeurope_pmcdocument de 6 observationsDOI 10.21203/rs.3.rs-2004891/v1

26,8 %26.8% of rural women in North Central Nigeria had fair/good knowledge of cervical cancer signs and symptoms.

Nigeriacancer du col de l'utéruspublié 2026Rural and remote healthPubMeddocument de 21 observations

2 092,5 parasite/μLThe age group >60 years recorded the highest mean malaria parasite density of 2092.50 parasite/μL of blood.

Nigeriapaludismepublié 2021Tropical biomedicinePubMeddocument de 6 observations

In multivariable linear regression analyses, the mean level of monocyte chemoattractant protein-1 was greater among those with HIV-associated neurocognitive disorders compared with the unimpaired (P = 0.047).

NigeriaHIV-associated neurocognitive disorders (HAND)publié 2020Journal of acquired immune deficiency syndromes (1999)PubMeddocument de 4 observations

88,9 %Eighty-one eyes of 72 (88.9%) patients had retinal vein occlusion.

Nigeriaretinal vein occlusionpublié 2023Annals of African medicinePubMeddocument de 5 observations

2 846 clientsOf the 7483 clients tracked, 2846 (38.2%) were lost to follow-up (LTFU).

NigeriaVIH/sidapublié 2019AIDS research and therapyPubMeddocument de 14 observations

38 000 000 inhabitantsThe estimated number of people living with HIV globally in 2018 was 38 million.

NigeriaVIH/sidaobservé 2018publié 2022The Journal of the Association of Nurses in AIDS Care : JANACPubMeddocument de 6 observations

hrHPV infection was defined as detection of at least one carcinogenic HPV genotype in a sample provided at the baseline visit.

NigeriahrHPV · infection à HPVpublié 2020BMC medical geneticsPubMeddocument de 6 observations

2,18 %The overall prevalence of rifampicin resistance TB among suspected tuberculosis and HIV patients in Benue State, Nigeria was 2.18%.

Nigeriarifampicin resistance TBobservé 2017–2018publié 2021The Pan African medical journalPubMeddocument de 4 observations

6 HPV_typesAmong these 25 HPV types in Nigeria, only six were included in the current nine-valent HPV vaccine.

Nigeriainfection à HPVpublié 2023Virology journalPubMeddocument de 8 observations

28,6 %Single HPV 16 infection occurred in 34 respondents (28.6%) of the 119 who consented to cervical cancer screening.

NigeriaHPV 16publié 2025BMC cancerPubMeddocument de 9 observations

Chaque ligne mène à son document source. Le nombre indiqué est celui des observations VALIDÉES qu'il porte, jamais celui des observations extraites : les deux diffèrent sur la plupart des documents. L'extrait exact du texte source n'est pas publié, par contrainte de droit d'auteur.